Developer docs
API playgroundTry for free, no card

Search company profiles

AIRA MATRIX

Full company profile

uuid0008f3q

Namestring
AIRA MATRIX
Legal namestring
AIRA Matrix
Websiteurl
airamatrix.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

AIRA Matrix is an India-based artificial intelligence company, founded in 2011 and headquartered in Thane, that develops image analysis and management solutions for preclinical toxicology and pathology applications. The company's core offering consists of computer-vision-based digital pathology tools designed to deliver automated quality control of pathology slides at a cited accuracy of over 98%, with applications spanning cancer detection, disease diagnosis, and workflow automation for pathologists. Its AI processes whole-slide pathology images to flag diagnostic and quality issues, addressing documented shortages of trained pathologists in rural and underserved settings.

The commercial model is OEM/embedded: AIRA Matrix licenses its AI tools to third-party digital pathology platform providers rather than selling directly to end users. The principal disclosed integration is with Histowiz's PathologyMap platform, through which the technology reaches pharmaceutical companies, biotechnology firms, academic institutions, and healthcare providers globally. This partner-led distribution gives the company international reach from a single India base without the cost of a direct enterprise sales motion. The company employs 101–250 people and is led by CEO Chaith Kondragunta, with founder Dilip Shanghvi, Umesh Shanghvi as Head of Innovation & Technology Development, and Nitin Singhal as Head of Products.

AIRA Matrix operates as a private, independent company. No institutional investors, funding rounds, acquisitions, subsidiaries, or regulatory certifications are disclosed in the available data. The company was recognized among the top 10 AI companies for digital pathology globally by Lumea Digital in 2024. Revenue is generated primarily through licensing and OEM integration fees, though specific contract values, customer concentration metrics, and revenue figures are not publicly disclosed.

Short descriptiontext

AIRA Matrix is an India-based AI company that develops computer vision tools for digital pathology, embedding its AI into third-party platforms such as Histowiz's PathologyMap to serve pharmaceutical, biotechnology, academic, and healthcare customers globally with automated slide quality control and diagnostic support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology AI, computational pathology, medical image analysis, preclinical toxicology software, cancer diagnostic AI
Industry5 codes
PRIMARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAALAL
Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial)
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools
NAICS code3 codes
  • Software Publishers51321
  • Software Publishers5132
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Digital Pathology AI Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1AI Technology Licensing and OEM Integration
TypeLicensing Royalties
Description

AIRA Matrix generates revenue by licensing its AI technology to digital pathology platform providers. Their AI tools are embedded into third-party platforms like Histowiz's PathologyMap, making them available to pharma, biotech, and academic institutions globally. This OEM/embedded model provides recurring licensing revenue from platform integrations.

timesofindia.indiatimes.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

AIRA Matrix develops and licenses AI-powered image analysis and management software for digital pathology and preclinical toxicology. Its core product consists of AI diagnostic tools that automate quality control and support cancer and disease detection on pathology slides, achieving over 98% accuracy. The tools are delivered through an OEM/embedded model into third-party digital pathology platforms such as Histowiz's PathologyMap, making them available to pharmaceutical companies, biotechnology firms, and academic institutions globally.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

AIRA Matrix is an India-based digital pathology AI company that provides AI-enabled tools for digital pathology analysis. The company's core offering consists of AI tools that integrate with platforms like PathologyMap to deliver automated quality control for pathology slides, achieving over 98% accuracy. These AI tools are made available to pharmaceutical, biotechnology, and academic institutions globally for cancer diagnostics and disease detection applications.

Product and service1 record
1AIRA Matrix AI Tools (Digital Pathology AI Suite)
CategoryDigital Pathology AI Software
Description

AI-powered software tools for digital pathology that automate quality control of pathology slides with over 98% accuracy and support cancer diagnostics and disease detection. Delivered as an OEM/embedded component inside third-party digital pathology platforms (e.g., Histowiz's PathologyMap) and used by pharmaceutical companies, biotechnology firms, and academic institutions globally.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

AIRA Matrix provides AI tools that are integrated into Histowiz's PathologyMap platform. PathologyMap is an AI-enabled digital pathology platform that achieves over 98% accuracy in automated quality control for pathology slides. The partnership makes AIRA Matrix's AI tools available to pharma, biotech and academic institutions globally through Histowiz's platform.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

PathAI develops AI-powered pathology solutions for cancer diagnosis and biomarker analysis. It is a direct competitor to AIRA Matrix, serving pharma, biotech, and clinical labs with similar computational pathology capabilities.

TypeDirect peer
Description

Paige builds AI for digital pathology with a focus on cancer detection and clinical-grade diagnostics. It is a direct pathology AI competitor targeting similar pharma and clinical customer segments as AIRA Matrix.

TypeDirect peer
Description

Owkin applies AI to pathology and biomedical research for pharma and biotech clients. It overlaps directly with AIRA Matrix's pathology AI offering for pharma/biotech R&D use cases.

TypeDirect peer
Description

Ibex provides AI-based cancer diagnostics for pathology labs and health systems. It is a direct peer in applying computer vision to pathology slides for diagnostic decision support.

TypeDirect peer
Description

Proscia is a digital pathology platform that embeds AI applications for pathology workflows. It is comparable because it operates both as a platform and an AI provider in the same ecosystem AIRA Matrix serves via Histowiz.

TypeDirect peer
Description

Visiopharm delivers image analysis and AI solutions for quantitative pathology. It targets pharma and research labs with similar AI-driven pathology tools, making it a direct comparability peer.

TypeDirect peer
Description

Indica Labs produces image analysis software for digital pathology, including AI-based workflows. It competes in the same pathology AI/image analysis space as AIRA Matrix for pharma and research customers.

TypeEmerging player
Description

Lumea is a digital pathology platform that has recognized AIRA Matrix as a top AI partner. It is an adjacent ecosystem participant whose platform could become a distribution channel similar to Histowiz.

TypeBroad incumbent
Description

Roche, through Ventana, is a broad incumbent in pathology diagnostics, including digital pathology and AI-enabled image analysis. It is comparable as a large-scale player overlapping with AIRA Matrix's customer base in clinical and pharma pathology.

TypeBroad incumbent
Description

Leica Biosystems provides digital pathology platforms and image management solutions used by pathology labs globally. It is a broad incumbent comparable to the platform ecosystem in which AIRA Matrix's AI is embedded.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AIRA MATRIX

Digital Pathology AI Softwareairamatrix.com

AIRA Matrix is an India-based AI company that develops computer vision tools for digital pathology, embedding its AI into third-party platforms such as Histowiz's PathologyMap to serve pharmaceutical, biotechnology, academic, and healthcare customers globally with automated slide quality control and diagnostic support.

What AIRA MATRIX does

AIRA Matrix is an India-based artificial intelligence company, founded in 2011 and headquartered in Thane, that develops image analysis and management solutions for preclinical toxicology and pathology applications. The company's core offering consists of computer-vision-based digital pathology tools designed to deliver automated quality control of pathology slides at a cited accuracy of over 98%, with applications spanning cancer detection, disease diagnosis, and workflow automation for pathologists. Its AI processes whole-slide pathology images to flag diagnostic and quality issues, addressing documented shortages of trained pathologists in rural and underserved settings.

The commercial model is OEM/embedded: AIRA Matrix licenses its AI tools to third-party digital pathology platform providers rather than selling directly to end users. The principal disclosed integration is with Histowiz's PathologyMap platform, through which the technology reaches pharmaceutical companies, biotechnology firms, academic institutions, and healthcare providers globally. This partner-led distribution gives the company international reach from a single India base without the cost of a direct enterprise sales motion. The company employs 101–250 people and is led by CEO Chaith Kondragunta, with founder Dilip Shanghvi, Umesh Shanghvi as Head of Innovation & Technology Development, and Nitin Singhal as Head of Products.

AIRA Matrix operates as a private, independent company. No institutional investors, funding rounds, acquisitions, subsidiaries, or regulatory certifications are disclosed in the available data. The company was recognized among the top 10 AI companies for digital pathology globally by Lumea Digital in 2024. Revenue is generated primarily through licensing and OEM integration fees, though specific contract values, customer concentration metrics, and revenue figures are not publicly disclosed.

AIRA MATRIX firmographics

Firmographics
Name
AIRA MATRIX
Legal name
AIRA Matrix
Website
https://airamatrix.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
AIRA Matrix is an India-based AI company that develops computer vision tools for digital pathology, embedding its AI into third-party platforms such as Histowiz's PathologyMap to serve pharmaceutical, biotechnology, academic, and healthcare customers globally with automated slide quality control and diagnostic support.
Ownership category
akta.pro rank

AIRA MATRIX industry classification

Industry
Product category
Digital Pathology AI Software
NAICS
Software Publishers (51321), Software Publishers (5132), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAALAL
Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial)
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools

Keywords

  • Digital pathology AI
  • Computational pathology
  • Medical image analysis
  • Preclinical toxicology software
  • Cancer diagnostic AI

Where AIRA MATRIX is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

AIRA MATRIX business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. AI Technology Licensing and OEM Integration: AIRA Matrix generates revenue by licensing its AI technology to digital pathology platform providers. Their AI tools are embedded into third-party platforms like Histowiz's PathologyMap, making them available to pharma, biotech, and academic institutions globally. This OEM/embedded model provides recurring licensing revenue from platform integrations.

Go-to-market motion1 record

Distribution channels1 record

AIRA MATRIX product offering

Product offering

Core offering

AIRA Matrix develops and licenses AI-powered image analysis and management software for digital pathology and preclinical toxicology. Its core product consists of AI diagnostic tools that automate quality control and support cancer and disease detection on pathology slides, achieving over 98% accuracy. The tools are delivered through an OEM/embedded model into third-party digital pathology platforms such as Histowiz's PathologyMap, making them available to pharmaceutical companies, biotechnology firms, and academic institutions globally.

Product overview

AIRA Matrix is an India-based digital pathology AI company that provides AI-enabled tools for digital pathology analysis. The company's core offering consists of AI tools that integrate with platforms like PathologyMap to deliver automated quality control for pathology slides, achieving over 98% accuracy. These AI tools are made available to pharmaceutical, biotechnology, and academic institutions globally for cancer diagnostics and disease detection applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • AIRA Matrix AI Tools (Digital Pathology AI Suite) AI-powered software tools for digital pathology that automate quality control of pathology slides with over 98% accuracy and support cancer diagnostics and disease detection. Delivered as an OEM/embedded component inside third-party digital pathology platforms (e.g., Histowiz's PathologyMap) and used by pharmaceutical companies, biotechnology firms, and academic institutions globally.

Companies that use AIRA MATRIX

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

AIRA MATRIX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature1 record

AIRA MATRIX partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • HistowizcoreTechnology or IntegrationAIRA Matrix provides AI tools that are integrated into Histowiz's PathologyMap platform. PathologyMap is an AI-enabled digital pathology platform that achieves over 98% accuracy in automated quality control for pathology slides. The partnership makes AIRA Matrix's AI tools available to pharma, biotech and academic institutions globally through Histowiz's platform.

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

AIRA MATRIX competitors and assessment

Company assessment

Direct peers

  • PathAI: PathAI develops AI-powered pathology solutions for cancer diagnosis and biomarker analysis. It is a direct competitor to AIRA Matrix, serving pharma, biotech, and clinical labs with similar computational pathology capabilities.
  • Paige.AI: Paige builds AI for digital pathology with a focus on cancer detection and clinical-grade diagnostics. It is a direct pathology AI competitor targeting similar pharma and clinical customer segments as AIRA Matrix.
  • Owkin: Owkin applies AI to pathology and biomedical research for pharma and biotech clients. It overlaps directly with AIRA Matrix's pathology AI offering for pharma/biotech R&D use cases.
  • Ibex Medical Analytics: Ibex provides AI-based cancer diagnostics for pathology labs and health systems. It is a direct peer in applying computer vision to pathology slides for diagnostic decision support.
  • Proscia: Proscia is a digital pathology platform that embeds AI applications for pathology workflows. It is comparable because it operates both as a platform and an AI provider in the same ecosystem AIRA Matrix serves via Histowiz.
  • Visiopharm: Visiopharm delivers image analysis and AI solutions for quantitative pathology. It targets pharma and research labs with similar AI-driven pathology tools, making it a direct comparability peer.
  • Indica Labs: Indica Labs produces image analysis software for digital pathology, including AI-based workflows. It competes in the same pathology AI/image analysis space as AIRA Matrix for pharma and research customers.

Emerging players

  • Lumea: Lumea is a digital pathology platform that has recognized AIRA Matrix as a top AI partner. It is an adjacent ecosystem participant whose platform could become a distribution channel similar to Histowiz.

Broad incumbents

  • Roche (Ventana): Roche, through Ventana, is a broad incumbent in pathology diagnostics, including digital pathology and AI-enabled image analysis. It is comparable as a large-scale player overlapping with AIRA Matrix's customer base in clinical and pharma pathology.
  • Leica Biosystems (Danaher): Leica Biosystems provides digital pathology platforms and image management solutions used by pathology labs globally. It is a broad incumbent comparable to the platform ecosystem in which AIRA Matrix's AI is embedded.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

AIRA MATRIX social profiles

Digital presence

AIRA MATRIX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AIRA MATRIX leadership team

Management profile

Number of profiles

Profiles4 records

AIRA MATRIX funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AIRA MATRIX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIRA MATRIX

What does AIRA MATRIX do?

AIRA Matrix develops and licenses AI-powered image analysis and management software for digital pathology and preclinical toxicology. Its core product consists of AI diagnostic tools that automate quality control and support cancer and disease detection on pathology slides, achieving over 98% accuracy. The tools are delivered through an OEM/embedded model into third-party digital pathology platforms such as Histowiz's PathologyMap, making them available to pharmaceutical companies, biotechnology firms, and academic institutions globally.

Is AIRA MATRIX a public or private company?

AIRA MATRIX is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AIRA MATRIX founded?

AIRA MATRIX was founded in 2011. It employs 101 to 250 people.

Where is AIRA MATRIX based?

AIRA MATRIX is headquartered in Mumbai, India, in the Asia region.

How does AIRA MATRIX make money?

One revenue line is on record: AI Technology Licensing and OEM Integration.

Who are AIRA MATRIX's main competitors?

Direct peers on record are PathAI, Paige.AI, Owkin, Ibex Medical Analytics, Proscia, Visiopharm and Indica Labs. Lumea is listed as an emerging player. Broad incumbents are Roche (Ventana) and Leica Biosystems (Danaher).

Does AIRA MATRIX have an API?

No public API is recorded for AIRA MATRIX.

What industry is AIRA MATRIX in?

AIRA MATRIX's product category is Digital Pathology AI Software. Its primary akta.pro industry code is HLAAALAO, Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 51321 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswiremTuitive & AIRA Matrix Partner to Connect AIRAProstate AI-powered DigitaL Pathology with Structured Pathology ReportingmTuitive and AIRA Matrix partnered to integrate AIRAProstate AI prostate findings into mTuitive's structured pathology reports. The integration allows pathologists to review AI results on digital slides and capture them as standardized data in synoptic reports. Availability of specific AIRA Matrix algorithms may vary by region and regulatory status.EIN PresswiremTuitive & AIRA Matrix Partner to Connect AIRAProstate AI-powered DigitaL Pathology with Structured Pathology ReportingmTuitive and AIRA Matrix partnered to integrate AIRAProstate AI prostate cancer findings into mTuitive's structured synoptic reports. The integration allows pathologists to view AI results on digital slides and capture them as standardized data, closing the gap between AI output and clinical reporting.EIN PresswireTechcyte integrates Aira Matrix AI into the Fusion AP digital pathology platformTechcyte integrated two Aira Matrix AI algorithms into its Fusion AP digital pathology platform: AIRAProstate for prostate biopsy analysis and AIRAQc for whole slide image quality control. AIRAProstate is available today, with AIRAQc integration underway. The integration aims to improve pathologist efficiency within a unified platform.The Times of IndiaAccelerating cancer diagnosis with AI-based pathologyThe article profiles Akash Parvatikar, who leads R&D of large-scale digital pathology platforms at Histowiz, a New York-based company, and has played a key role in building PathologyMap, an AI-enabled platform that achieves over 98% accuracy in automated quality control for pathology slides. PathologyMap integrates AI tools developed by AIRA Matrix, an India-based digital pathology AI company, making them available to pharma, biotech and academic institutions globally. The article discusses how digital pathology could help address India's shortage of trained pathologists in rural and semi-urban areas, while noting challenges including the high cost of slide scanners (Rs 50 lakh to Rs 2 crore) and the need for national data standards and regulatory frameworks.LagrandeobserverInnovative Partnership: AIRA Matrix Partners with Gestalt to Elevate Diagnostics with AI-Driven QC PlatformAIRA Matrix and Gestalt Diagnostics announced a partnership to integrate AIRA Matrix's AI-driven quality control platform, AIRAQC, into Gestalt's PathFlow digital pathology workflow. The collaboration aims to enhance diagnostic precision and efficiency in laboratories worldwide.PR NewswireInnovative Partnership: AIRA Matrix Partners with Gestalt to Elevate Diagnostics with AI-Driven QC PlatformAIRA Matrix and Gestalt Diagnostics announced a partnership to integrate AIRA Matrix's AI-driven quality control platform, AIRAQC, into Gestalt's PathFlow digital pathology workflow. The collaboration aims to enhance diagnostic precision and efficiency in laboratories worldwide.YahooInnovative Partnership: AIRA Matrix Partners with Gestalt to Elevate Diagnostics with AI-Driven QC PlatformAIRA Matrix and Gestalt Diagnostics announced a partnership to integrate AIRA Matrix's AI-driven quality control platform, AIRAQC, into Gestalt's PathFlow digital pathology workflow. The collaboration aims to enhance diagnostic precision and efficiency in laboratories worldwide.GestaltdiagnosticsInnovative Partnership: AIRA Matrix Partners with Gestalt to Elevate Diagnostics with AI-Driven QC PlatformAIRA Matrix and Gestalt Diagnostics have formed a strategic partnership to integrate AIRA Matrix's AI-driven quality control solution, AIRAQC, into Gestalt's PathFlow digital pathology platform. This collaboration aims to enhance diagnostic precision and efficiency for laboratories worldwide by streamlining quality control processes within pathology workflows.